NPPA notified regarding the fixation of the

Sep 05, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on September 03, 2024, notified regarding the fixation of the retail price of Abacavir Sulfate USP eq. to 600 mg of Abacavir + Dolutegravir Sodium eq. to 50 mg of Dolutegravir + Lamivudine USP 300 mg.

The following has been stated namely: -

• It has fixed the rate at Rs. 161.10/- for the Composition of each film-coated tablet Containing: Abacavir Sulfate USP eq. to 600 mg of Abacavir + Dolutegravir Sodium eq. to 50 mg of Dolutegravir + Lamivudine USP 300 mg.

[Notification no. - 19(4146)/2024/DP/NPPA/DIV.II]

View Document 1